Response to low dose indomethacin in two children with nephrogenic diabetes insipidus

Devi Dayal; Savita Verma Attri; Anil Kumar Bhalla; Rakesh Kumar

eISSN: 2083-8441
ISSN: 2081-237X

Pediatric Endocrinology Diabetes and Metabolism

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

Journal integrated with

4/2014
vol. 20

Send email

Copy url:

abstract:

Case report

Response to low dose indomethacin in two children with nephrogenic diabetes insipidus

Devi Dayal

,

Savita Verma Attri

,

Anil Kumar Bhalla

,

Rakesh Kumar

Pediatr Endocrinol Diabetes Metab 2014;22,4:178-181

Online publish date: 2015/08/31

View full text Get citation

Two children with nephrogenic diabetes insipidus (NDI) were treated with oral indomethacin (0.75-1.2 mg/kg/day) three times a day for a mean duration of 3 yrs. Remission occurred in both patients in terms of achieving a normal fluid balance and body growth and the drug was withdrawn in one patient after 2 yrs. The treatment was well tolerated and no side effects were noted. The mean duration of follow-up was 6.5 yrs. These long-term observations of a favourable response to low dose indomethacin in 2 children with NDI need to be tested on larger number of patients.

keywords:

Response to low dose indomethacin in two children with nephrogenic diabetes insipidus

Devi Dayal , Savita Verma Attri , Anil Kumar Bhalla , Rakesh Kumar

nephrogenic diabetes insipidus, cyclooxygenase inhibitors, indomethacin, children

Devi Dayal

,

Savita Verma Attri

,

Anil Kumar Bhalla

,

Rakesh Kumar